Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Innovative Administration of Long-Acting Injectables for HIV Treatment Enhancement at Home

NCT06488846 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT06488846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06488846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Innovative Administration of Long-Acting Injectables for HIV Treatment Enhancement at Home
Lead sponsor
University of California, San Francisco
Phase
Observational
Overall status
Enrolling by invitation
Start date
February 16, 2026
Completion date
September 29, 2027
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections